Causes of death in patients with asthma and asthma–chronic obstructive pulmonary disease overlap syndrome

International Journal of COPD

Volumn 10, Issue , 2015, Pages 595-602

  Harada, Tomoya ^a   Yamasaki, Akira ^a   Fukushima, Takehito ^a   Hashimoto, Kiyoshi ^a   Takata, Miki ^a   Kodani, Masahiro ^a   Okazaki, Ryota ^a   Takeda, Kenichi ^a   Watanabe, Masanari ^a   Kurai, Jun ^a   Shimizu, Eiji ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

Asthma; Asthma COPD overlap syndrome; Chronic obstructive pulmonary disease; Mortality

Indexed keywords

ADULT; AGED; ARTICLE; ASTHMA; ASTHMA CHRONIC OBSTRUCTIVE LUNG DISEASE OVERLAP SYNDROME; CAUSE OF DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; FEMALE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDICAL RECORD REVIEW; MORTALITY; RETROSPECTIVE STUDY; UNIVERSITY HOSPITAL; COMPARATIVE STUDY; EPIDEMIOLOGY; MIDDLE AGED; NEOPLASMS; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTOR; SYNDROME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ASTHMA; CAUSE OF DEATH; COMORBIDITY; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; NEOPLASMS; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; RISK FACTORS; SYNDROME;

EID: 84929415616     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S77491     Document Type: Article

References (40)

1. Asher MI, Montefort S, Bjorksten B, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet. 2006;368(9537):733–743.
2. Shimizu K, Konno S, Kimura H, et al. [Prevalence of adult asthma and allergic rhinitis in Kamishihoro, Hokkaido-trends from 2006 through 2011]. Arerugi. 2014;63(7):928–937. Japanese.
3. Ohta K, Ichinose M, Nagase H, et al. Japanese guideline for adult asthma 2014. Allergology. 2014;63(3):293–333.
4. Suissa S, Ernst P, Benayoun S, Baltzan M, Cai B. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med. 2000;343(5):332–336.
5. Statistics and Information Department, Minister’s Secretariat, Ministry of Health and Welfare, Japan. Vital Statistics Japan 3. Tokyo, Japan: Health and Welfare Statistics Association; 2012–2013.
6. Ito Y, Tamakoshi A, Wakai K, Takagi K, Yamaki K, Ohno Y. Trends in asthma mortality in Japan. J Asthma. 2002;39(7):633–639.
7. Tsai CL, Lee WY, Hanania NA, Camargo CA Jr. Age-related differences in clinical outcomes for acute asthma in the United States, 2006–2008. J Allergy Clin Immunol. 2012;129(5):1252–1258. e1251.
8. Gibson PG, McDonald VM, Marks GB. Asthma in older adults. Lancet. 2010;376(9743):803–813.
9. Iwanaga T, Tohda Y. [Bronchial asthma: progress in diagnosis and treatments. Topics: I. Basic knowledge; 3. Asthma in the elderly]. Nihon Naika Gakkai Zasshi. 2013;102(6):1343–1351. Japanese.
10. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095–2128.
11. Soto-Campos JG, Plaza V, Soriano JB, et al. Causes of death in asthma, COPD and non-respiratory hospitalized patients: a multicentric study. BMC Pulm Med. 2013;13:73.
12. Zielinski J, MacNee W, Wedzicha J, et al. Causes of death in patients with COPD and chronic respiratory failure. Monaldi Arch Chest Dis. 1997;52(1):43–47.
13. Garcia-Aymerich J, Farrero E, Felez MA, Izquierdo J, Marrades RM, Anto JM. Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax. 2003;58(2):100–105.
14. Sin DD, Anthonisen NR, Soriano JB, Agusti AG. Mortality in COPD: role of comorbidities. Eur Respir J. 2006;28(6):1245–1257.
15. Wilson DO, Weissfeld JL, Balkan A, et al. Association of radiographic emphysema and airflow obstruction with lung cancer. Am J Respir Crit Care Med. 2008;178(7):738–744.
16. Gibson PG, Simpson JL. The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax. 2009;64(8):728–735.
17. Menezes AM, Montes de Oca M, Perez-Padilla R, et al. Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma. Chest. 2014;145(2):297–304.
18. Pleasants RA, Ohar JA, Croft JB, et al. Chronic obstructive pulmonary disease and asthma-patient characteristics and health impairment. COPD. 2014;11(3):256–266.
19. Diagnosis of Diseases of Chronic Airflow Limitation: Asthma COPD and Asthma-COPD Overlap Syndrome (ACOS). Based on the Global Strategy for Asthma Management and Prevention and the Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease, 2014. Available from: http://www.ginasthma.org/local/uploads/files/AsthmaCOPDOverlap.pdf. Accessed February 3, 2015.
20. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. Am Rev Respir Dis. 1987;136(1):225–244.
21. Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD). Global Strategy for Diagnosis, Management and Prevention of COPD. 2014. Available from: http://www.goldcopd.org/guidelines-global-strategy-for-diagnosis-management.html. Accessed February 3, 2015.
22. Reed CE. The natural history of asthma. J Allergy Clin Immunol. 2006;118(3):543–548.
23. Bauer BA, Reed CE, Yunginger JW, Wollan PC, Silverstein MD.: Incidence and outcomes of asthma in the elderly. A population-based study in Rochester, Minnesota. Chest. 1997;111(2):303–310.
24. Silverstein MD, Reed CE, O’Connell EJ, Melton LJ III, O’Fallon WM, Yunginger JW. Long-term survival of a cohort of community residents with asthma. N Engl J Med. 1994;331(23):1537–1541.
25. Reed CE.: Onset and outcome of asthma in older adults. A clinician’s perspective. Clin Rev Allergy Immunol. 2002;22(1):53–65.
26. Rodriguez-Roisin R, Soriano JB. Chronic obstructive pulmonary disease with lung cancer and/or cardiovascular disease. Proc Am Thorac Soc. 2008;5(8):842–847.
27. Rosenberger A, Bickeboller H, McCormack V, et al. Asthma and lung cancer risk: a systematic investigation by the International Lung Cancer Consortium. Carcinogenesis. 2012;33(3):587–597.
28. Denholm R, Schuz J, Straif K, et al. Is previous respiratory disease a risk factor for lung cancer? Am J Respir Crit Care Med. 2014;190(5):549–559.
29. Wang H, Diepgen TL. Is atopy a protective or a risk factor for cancer? A review of epidemiological studies. Allergy. 2005;60(9):1098–1111.
30. Chatila WM, Thomashow BM, Minai OA, Criner GJ, Make BJ. Comorbidities in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2008;5(4):549–555.
31. de Torres JP, Bastarrika G, Wisnivesky JP, et al. Assessing the relationship between lung cancer risk and emphysema detected on low-dose CT of the chest. Chest. 2007;132(6):1932–1938.
32. Zulueta JJ, Wisnivesky JP, Henschke CI, et al. Emphysema scores predict death from COPD and lung cancer. Chest. 2012;141(5):1216–1223.
33. Lundback B, Lindberg A, Lindstrom M, et al. Not 15 but 50% of smokers develop COPD? – Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med. 2003;97(2):115–122.
34. Hagstad S, Ekerljung L, Lindberg A, Backman H, Ronmark E, Lundback B. COPD among non-smokers – report from the Obstructive Lung Disease in Northern Sweden (OLIN) studies. Respir Med. 2012;106(7):980–988.
35. Tai A, Tran H, Roberts M, Clarke N, Wilson J, Robertson CF. The association between childhood asthma and adult chronic obstructive pulmonary disease. Thorax. 2014;69(9):805–810.
36. Silva GE, Sherrill DL, Guerra S, Barbee RA. Asthma as a risk factor for COPD in a longitudinal study. Chest. 2004;126(1):59–65.
37. Decramer M, Celli B, Kesten S, Lystig T, Mehra S, Tashkin DP. Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial. Lancet. 2009;374(9696):1171–1178.
38. D’Urzo A, Ferguson GT, van Noord JA, et al. Efficacy and safety of once-daily NVA237 in patients with moderate-to-severe COPD: the GLOW1 trial. Respir Res. 2011;12:156.
39. Soriano JB, Davis KJ, Coleman B, Visick G, Mannino D, Pride NB. The proportional Venn diagram of obstructive lung disease: two approximations from the United States and the United Kingdom. Chest. 2003;124(2):474–481.
40. de Marco R, Pesce G, Marcon A, et al. The coexistence of asthma and chronic obstructive pulmonary disease (COPD): prevalence and risk factors in young, middle-aged and elderly people from the general population. PLoS One. 2013;8(5):e62985.